Race, income can determine blood cancer outcomes, studies show
If someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.
Dec 12, 2022
0
19
Hemic and Lymphatic Diseases: News and Research on Lymphoma, B-Cell
MeSH tree: C15.604.515.569.480.150
Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas
Using a novel response-adapted ultra-low dose radiation therapy strategy, researchers at The University of Texas MD Anderson Cancer Center observed a 90% complete response rate in patients with orbital indolent B-cell lymphoma. ...
Oct 24, 2022
0
33
Enzyme inhibitor slows tumor growth
Together with researchers from University Hospital Mainz, the University of Regensburg and the IRCM in Montreal (Canada), a research team from Friedrich Schiller University Jena has discovered a novel therapeutic approach ...
Sep 21, 2022
0
50
Study of cancer immunotherapy patients reveals markers of treatment response
The treatment of blood cancers has dramatically improved in the last five years, thanks to a new class of cancer immunotherapies called CAR-T cell therapy. This therapy—which involves engineering a patient's own T cells in ...
Sep 13, 2022
0
76
New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer
The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Marginal Zone Lymphoma. A cancer of the lymphatic system, marginal zone lymphoma (MZL) is a type of non-Hodgkin B-cell lymphoma ...
Sep 12, 2022
0
82
Researchers use custom molecule to halt growth of multiple myeloma and diffuse large B cell lymphoma in mice
Researchers at Stanford University have developed "decoy receptor" molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to ...
Jul 26, 2022
0
68
